Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors

NCT00743379 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Prostate Cancer
Pancreatic Cancer

Interventions

DRUG: TH-302

Sponsor

Threshold Pharmaceuticals